Case report: Application of nirmatrelvir/ritonavir to treat COVID-19 in a severe aplastic anemia child after allogeneic hematopoietic stem cell transplantation

Case report: Application of nirmatrelvir/ritonavir to treat COVID-19 in a severe aplastic anemia child after allogeneic hematopoietic stem cell transplantation

We present a case report of successful treatment with nirmatrelvir/ritonavir (Paxlvoid) for a severe aplastic anemia child with COVID-19, cytopenia, and mixed chimerism of donor hematopoietic cells at 3 months after allogeneic hematopoietic stem cell transplantation. After the 5-day entire course of...

Full description

Bibliographic Details
Main Authors: Jinhua Huang, Di Yin, Xia Qin, Mei Yu, Beilei Jiang, Jing Chen, Qing Cao, Zhiguo Tang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Pediatrics
Subjects:
COVID-19
children
Paxlovid
severe aplastic anemia
transplantation
Omicron
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2022.935118/full

Internet

https://www.frontiersin.org/articles/10.3389/fped.2022.935118/full

Similar Items